143 related articles for article (PubMed ID: 22213390)
21. Polymorphisms in metabolic GSTP1 and DNA-repair XRCC1 genes with an increased risk of DNA damage in pesticide-exposed fruit growers.
Wong RH; Chang SY; Ho SW; Huang PL; Liu YJ; Chen YC; Yeh YH; Lee HS
Mutat Res; 2008 Jul; 654(2):168-75. PubMed ID: 18603015
[TBL] [Abstract][Full Text] [Related]
22. Polymorphism in DNA repair genes and oral squamous cell carcinoma in Thailand.
Kietthubthew S; Sriplung H; Au WW; Ishida T
Int J Hyg Environ Health; 2006 Jan; 209(1):21-9. PubMed ID: 16373199
[TBL] [Abstract][Full Text] [Related]
23. XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.
Gurubhagavatula S; Liu G; Park S; Zhou W; Su L; Wain JC; Lynch TJ; Neuberg DS; Christiani DC
J Clin Oncol; 2004 Jul; 22(13):2594-601. PubMed ID: 15173214
[TBL] [Abstract][Full Text] [Related]
24. MnSOD rs4880 and XPD rs13181 polymorphisms predict the survival of breast cancer patients treated with adjuvant tamoxifen.
Tengström M; Mannermaa A; Kosma VM; Soini Y; Hirvonen A; Kataja V
Acta Oncol; 2014 Jun; 53(6):769-75. PubMed ID: 24716840
[TBL] [Abstract][Full Text] [Related]
25. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; Selvaggi G; Gregori D; DeMarchi M; Scagliotti GV
Clin Cancer Res; 2007 May; 13(10):2876-81. PubMed ID: 17504986
[TBL] [Abstract][Full Text] [Related]
26. Influences of ERCC1, ERCC2, XRCC1, GSTP1, GSTT1, and MTHFR polymorphisms on clinical outcomes in gastric cancer patients treated with EOF chemotherapy.
Liu R; Zhao X; Liu X; Chen Z; Qiu L; Geng R; Guo W; He G; Yin J; Li J; Zhu X
Tumour Biol; 2016 Feb; 37(2):1753-62. PubMed ID: 26314858
[TBL] [Abstract][Full Text] [Related]
27. Genetic polymorphisms of glutathione S-transferase genes GSTP1, GSTM1, and GSTT1 and risk of esophageal and gastric cardia cancers.
Zendehdel K; Bahmanyar S; McCarthy S; Nyren O; Andersson B; Ye W
Cancer Causes Control; 2009 Dec; 20(10):2031-8. PubMed ID: 19618282
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
[TBL] [Abstract][Full Text] [Related]
29. Specific combinations of DNA repair gene variants and increased risk for non-small cell lung cancer.
Popanda O; Schattenberg T; Phong CT; Butkiewicz D; Risch A; Edler L; Kayser K; Dienemann H; Schulz V; Drings P; Bartsch H; Schmezer P
Carcinogenesis; 2004 Dec; 25(12):2433-41. PubMed ID: 15333465
[TBL] [Abstract][Full Text] [Related]
30. DNA Repair Genes XRCC1, XRCC3, XPD, and OGG1 Polymorphisms among the Central Region Population of Saudi Arabia.
Alanazi M; Pathan AA; Ajaj SA; Khan W; Shaik JP; Al Tassan N; Parine NR
Biol Res; 2013; 46(2):161-7. PubMed ID: 23959014
[TBL] [Abstract][Full Text] [Related]
31. Inherited susceptibility to bleomycin-induced micronuclei: correlating polymorphisms in GSTT1, GSTM1 and DNA repair genes with mutagen sensitivity.
Angelini S; Kumar R; Carbone F; Bermejo JL; Maffei F; Cantelli-Forti G; Hemminki K; Hrelia P
Mutat Res; 2008 Feb; 638(1-2):90-7. PubMed ID: 17953974
[TBL] [Abstract][Full Text] [Related]
32. A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.
Park DJ; Stoehlmacher J; Zhang W; Tsao-Wei DD; Groshen S; Lenz HJ
Cancer Res; 2001 Dec; 61(24):8654-8. PubMed ID: 11751380
[TBL] [Abstract][Full Text] [Related]
33. GSTT1, GSTM1, and GSTP1 polymorphisms and chemotherapy response in locally advanced breast cancer.
Oliveira AL; Rodrigues FF; Santos RE; Aoki T; Rocha MN; Longui CA; Melo MB
Genet Mol Res; 2010 Jun; 9(2):1045-53. PubMed ID: 20568049
[TBL] [Abstract][Full Text] [Related]
34. Glutathione S-transferase polymorphisms and ovarian cancer treatment and survival.
Beeghly A; Katsaros D; Chen H; Fracchioli S; Zhang Y; Massobrio M; Risch H; Jones B; Yu H
Gynecol Oncol; 2006 Feb; 100(2):330-7. PubMed ID: 16199080
[TBL] [Abstract][Full Text] [Related]
35. Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer.
Pratesi N; Mangoni M; Mancini I; Paiar F; Simi L; Livi L; Cassani S; Buglione M; Grisanti S; Almici C; Polli C; Saieva C; Magrini SM; Biti G; Pazzagli M; Orlando C
Radiother Oncol; 2011 Jun; 99(3):356-61. PubMed ID: 21704413
[TBL] [Abstract][Full Text] [Related]
36. Influence of genetic polymorphisms on frequency of micronucleated buccal epithelial cells in leukoplakia patients.
Mahimkar MB; Samant TA; Kannan S; Patil T
Oral Oncol; 2010 Oct; 46(10):761-6. PubMed ID: 20850372
[TBL] [Abstract][Full Text] [Related]
37. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
38. Association of the DNA repair gene XPD Asp312Asn polymorphism with p53 gene mutations in tobacco-related non-small cell lung cancer.
Gao WM; Romkes M; Day RD; Siegfried JM; Luketich JD; Mady HH; Melhem MF; Keohavong P
Carcinogenesis; 2003 Oct; 24(10):1671-6. PubMed ID: 12844488
[TBL] [Abstract][Full Text] [Related]
39. Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy.
Ryu JS; Hong YC; Han HS; Lee JE; Kim S; Park YM; Kim YC; Hwang TS
Lung Cancer; 2004 Jun; 44(3):311-6. PubMed ID: 15140544
[TBL] [Abstract][Full Text] [Related]
40. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer.
Hansen RD; Sørensen M; Tjønneland A; Overvad K; Wallin H; Raaschou-Nielsen O; Vogel U
Mutat Res; 2007 Jun; 619(1-2):68-80. PubMed ID: 17363013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
